HOME >> BIOLOGY >> NEWS
New Northwestern center targets brain disorders

combining molecular biology and gene discovery with the pragmatism of engineering in order to solve this problem and others."

The second potential therapy is based on the discovery by Moskal and colleagues of a family of molecules called glyxins that appear to enhance learning and memory. The Food and Drug Administration recently approved the glyxins for human phase I trials.

"The glyxins also may have an impact on attention deficit hyperactivity disorder, memory loss associated with the early stages of Alzheimer's disease as well as normal aging, damage due to stroke, and neuropathic pain," said Moskal. He has collaborated for years with John Disterhoft, professor of physiology at Feinberg, in evaluating the compounds.

Recently, another long-time collaborator, Jaak Panksepp, an emeritus professor in the psychology department at Bowling Green State University, joined the Falk Center as head of its affective neuroscience research program.

The Falk Center puts state-of-the-art gene chip technology -- the same used to discover the glyxins and the brain tumor therapy -- into the hands of Northwestern faculty and students. This technology, used to identify gene targets for new therapeutics, is more often found in the private sector than in universities.

"Very few universities in the country have direct access to gene chip technology of this caliber," said Roger Kroes, chief of molecular neuro-oncology at Falk and assistant research professor of biomedical engineering. "In the Chicago area, only a handful of programs in academia and the private sector combined have facilities equivalent to the Falk Center's."

Moskal and his staff build their own microarrays from scratch and are continually evolving the technology. Now they can train faculty, undergraduate and graduate students, and visiting scholars to build customized gene chips for their own discoveries. Moskal and his staff already have taught a class in advanced mo
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
10-Feb-2003


Page: 1 2 3

Related biology news :

1. Northwesterns Cancer Genetics Program pinpoints gene that increases cancer risk by 26 percent
2. Northwestern receives $5.65 million for reproductive research
3. Northwestern launches major gene banking project
4. A little larceny comes naturally to Northwestern crows
5. Northwestern receives $17 million for functional genomics research
6. Northwestern program aims at revealing genetic causes of spina bifida
7. Northwestern researchers map gene mutation that makes mice deaf and causes them to dance
8. Northwestern scientists shed new light on neurodegenerative diseases
9. Northwestern researchers clone gene responsible for inner ear motor
10. Northwestern team identifies first enzyme in mammalian circadian clock
11. Northwestern Hosts Public Forum On Future Of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/3/2016)... , June 3, 2016 ... Management) von Nepal ... und Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, ... führend in der Produktion und Implementierung von ... der Ausschreibung im Januar teilgenommen, aber Decatur ...
(Date:6/2/2016)... Perimeter Surveillance & Detection Systems, ... Infrastructure, Support & Other Service  The latest ... comprehensive analysis of the global Border Security market ... of $17.98 billion in 2016. Now: In ... in software and hardware technologies for advanced video surveillance. ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
Breaking Biology News(10 mins):
(Date:6/22/2016)... Research and Markets has announced the addition of the ... The global biomarkers market has ... The market is expected to grow at a five-year compound annual ... $50.6 billion in 2015 to $96.6 billion in 2020. ... to 2020) are discussed. As well, new products approved in 2013 ...
(Date:6/22/2016)... 2016   StockNewsNow.com , The Official MicroCap News ... Nader Pourhassan , President & CEO of CytoDyn ... clinical development and potential commercialization of humanized monoclonal antibodies ... to the company,s website (see here: www.CytoDyn.com ). ... th , 2016, at the LD Micro Invitational in ...
(Date:6/22/2016)... --  ViaCyte, Inc. , a privately-held regenerative medicine company ... for the treatment of diabetes in clinical-stage development, today ... 2016, the Global Stem Cell Event, is taking place ... Francisco.    ... Focus Session: Tools for Basic and Applied Stem Cell ...
(Date:6/22/2016)... ... June 22, 2016 , ... ... spotlight on immigrant achievements and contributions to North Texas and the nation, recently ... from the immigrant community to the civic and economic vitality of North Texas. ...
Breaking Biology Technology:
Cached News: